Mesenchymal Stem Cell Graft Improves Recovery after Spinal Cord Injury in Adult Rats through Neurotrophic and Pro-Angiogenic Actions

Numerous strategies have been managed to improve functional recovery after spinal cord injury (SCI) but an optimal strategy doesn't exist yet. Actually, it is the complexity of the injured spinal cord pathophysiology that begets the multifactorial approaches assessed to favour tissue protection, axonal regrowth and functional recovery. In this context, it appears that mesenchymal stem cells (MSCs) could take an interesting part. The aim of this study is to graft MSCs after a spinal cord compression injury in adult rat to assess their effect on functional recovery and to highlight their mechanisms of action. We found that in intravenously grafted animals, MSCs induce, as early as 1 week after the graft, an improvement of their open field and grid navigation scores compared to control animals. At the histological analysis of their dissected spinal cord, no MSCs were found within the host despite their BrdU labelling performed before the graft, whatever the delay observed: 7, 14 or 21 days. However, a cytokine array performed on spinal cord extracts 3 days after MSC graft reveals a significant increase of NGF expression in the injured tissue. Also, a significant tissue sparing effect of MSC graft was observed. Finally, we also show that MSCs promote vascularisation, as the density of blood vessels within the lesioned area was higher in grafted rats. In conclusion, we bring here some new evidences that MSCs most likely act throughout their secretions and not via their own integration/differentiation within the host tissue.

[1]  A. Mackay-Sim,et al.  Combined VEGF and PDGF treatment reduces secondary degeneration after spinal cord injury. , 2012, Journal of neurotrauma.

[2]  L. Sommer,et al.  RETRACTED ARTICLE: Mesenchymal stem cells and neural crest stem cells from adult bone marrow: characterization of their surprising similarities and differences , 2012, Cellular and Molecular Life Sciences.

[3]  S. Lalwani,et al.  Spinal cord injury. , 2011, Journal of neurosurgery. Spine.

[4]  M. Fehlings,et al.  A systematic review of cellular transplantation therapies for spinal cord injury. , 2011, Journal of neurotrauma.

[5]  A. Miyawaki,et al.  Comparative Study of Methods for Administering Neural Stem/Progenitor Cells to Treat Spinal Cord Injury in Mice , 2011, Cell transplantation.

[6]  Yue Li,et al.  Olfactory ensheathing cells can reduce the tissue loss but not the cavity formation in contused spinal cord of rats , 2011, Journal of the Neurological Sciences.

[7]  P. Narayana,et al.  Effect of vascular endothelial growth factor treatment in experimental traumatic spinal cord injury: in vivo longitudinal assessment. , 2011, Journal of neurotrauma.

[8]  F. Benvenuto,et al.  Neuroprotective features of mesenchymal stem cells. , 2011, Best practice & research. Clinical haematology.

[9]  S. Kang,et al.  Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. , 2011, Stem cells and development.

[10]  R. Bellamkonda,et al.  Sustained Delivery of Activated Rho GTPases and BDNF Promotes Axon Growth in CSPG-Rich Regions Following Spinal Cord Injury , 2011, PloS one.

[11]  F. Wang,et al.  Intravenous transplantation of allogeneic bone marrow mesenchymal stem cells and its directional migration to the necrotic femoral head , 2011, International journal of medical sciences.

[12]  I. Sekiya,et al.  Transplantation of neuronal cells induced from human mesenchymal stem cells improves neurological functions after stroke without cell fusion , 2010, Journal of neuroscience research.

[13]  W. Masri,et al.  Concise Review: Bone Marrow for the Treatment of Spinal Cord Injury: Mechanisms and Clinical Applications , 2010, Stem cells.

[14]  Jeff W M Bulte,et al.  Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. , 2010, Archives of neurology.

[15]  Andrea Augello,et al.  Mesenchymal stem cells: a perspective from in vitro cultures to in vivo migration and niches. , 2010, European cells & materials.

[16]  Jee-Yin Ahn,et al.  Neuroprotection signaling pathway of nerve growth factor and brain-derived neurotrophic factor against staurosporine induced apoptosis in hippocampal H19-7 cells , 2010, Experimental & Molecular Medicine.

[17]  G. Onose,et al.  Molecular basis of vascular events following spinal cord injury , 2010, Journal of medicine and life.

[18]  S. Hamdy,et al.  Case Control Series of Intrathecal Autologous Bone Marrow Mesenchymal Stem Cell Therapy for Chronic Spinal Cord Injury , 2010, Neurorehabilitation and neural repair.

[19]  K. Houkin,et al.  Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome , 2010, Brain Research.

[20]  A. Webb,et al.  Spinal cord injury I: A synopsis of the basic science. , 2010, The Canadian veterinary journal = La revue veterinaire canadienne.

[21]  J. Veltman,et al.  Functional differences between mesenchymal stem cell populations are reflected by their transcriptome. , 2010, Stem cells and development.

[22]  S. Whittemore,et al.  Transplantation of Ciliary Neurotrophic Factor-Expressing Adult Oligodendrocyte Precursor Cells Promotes Remyelination and Functional Recovery after SpinalCord Injury , 2010, The Journal of Neuroscience.

[23]  J. Grotenhuis,et al.  Bone marrow stromal cells elicit tissue sparing after acute but not delayed transplantation into the contused adult rat thoracic spinal cord. , 2009, Journal of neurotrauma.

[24]  K. Houkin,et al.  BDNF-Hypersecreting Human Mesenchymal Stem Cells Promote Functional Recovery, Axonal Sprouting, and Protection of Corticospinal Neurons after Spinal Cord Injury , 2009, The Journal of Neuroscience.

[25]  R. Betz,et al.  Transplantation of Human Marrow Stromal Cells and Mono-Nuclear Bone Marrow Cells Into the Injured Spinal Cord: A Comparative Study , 2009, Spine.

[26]  A. Howard,et al.  CD133 identifies a human bone marrow stem/progenitor cell sub-population with a repertoire of secreted factors that protect against stroke. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[27]  D. Covas,et al.  Mechanisms involved in the therapeutic properties of mesenchymal stem cells. , 2009, Cytokine & growth factor reviews.

[28]  T. Nishio Axonal regeneration and neural network reconstruction in mammalian CNS , 2009, Journal of Neurology.

[29]  Xiao-dan Jiang,et al.  Combination of bone marrow stromal cell transplantation with mobilization by granulocyte-colony stimulating factor promotes functional recovery after spinal cord transection , 2009, Acta Neurochirurgica.

[30]  S. Amini,et al.  Monocyte chemoattractant protein-1 (MCP-1): an overview. , 2009, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[31]  Jeffrey M Karp,et al.  Mesenchymal stem cell homing: the devil is in the details. , 2009, Cell stem cell.

[32]  H. Okano,et al.  Development of mesenchymal stem cells partially originate from the neural crest. , 2009, Biochemical and biophysical research communications.

[33]  B. Min,et al.  GM-CSF inhibits glial scar formation and shows long-term protective effect after spinal cord injury , 2009, Journal of the Neurological Sciences.

[34]  R. Betz,et al.  Grafting of Human Bone Marrow Stromal Cells Into Spinal Cord Injury: A Comparison of Delivery Methods , 2009, Spine.

[35]  Steven J. Greco,et al.  A method to generate human mesenchymal stem cell-derived neurons which express and are excited by multiple neurotransmitters , 2008, Biological Procedures Online.

[36]  I. Fischer,et al.  Effects of plating density and culture time on bone marrow stromal cell characteristics. , 2008, Experimental hematology.

[37]  H. Okano,et al.  Ontogeny and multipotency of neural crest-derived stem cells in mouse bone marrow, dorsal root ganglia, and whisker pad. , 2008, Cell stem cell.

[38]  I. B. Borel Rinkes,et al.  Mesenchymal Stem Cell Therapy for Protection and Repair of Injured Vital Organs , 2008 .

[39]  M. Coutts,et al.  Stem cells for treatment of spinal cord injury , 2008, Experimental Neurology.

[40]  J. Yoshida,et al.  Intravenously transplanted human neural stem cells migrate to the injured spinal cord in adult mice in an SDF-1- and HGF-dependent manner , 2007, Neuroscience Letters.

[41]  Charles Tator,et al.  Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury , 2007, Bone Marrow Transplantation.

[42]  C. V. van Blitterswijk,et al.  Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering , 2007, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[43]  Feng Zhao,et al.  Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. , 2007, Biochemical and biophysical research communications.

[44]  Michael R Rosen,et al.  Mesenchymal Stem Cells Support Migration, Extracellular Matrix Invasion, Proliferation, and Survival of Endothelial Cells In Vitro , 2007, Stem cells.

[45]  T. Wang,et al.  Neural differentiation of mesenchymal-like stem cells from cord blood is mediated by PKA. , 2007, Biochemical and biophysical research communications.

[46]  G. Raisman Repair of spinal cord injury by transplantation of olfactory ensheathing cells. , 2007, Comptes rendus biologies.

[47]  B. Choi,et al.  GM-CSF inhibits apoptosis of neural cells via regulating the expression of apoptosis-related proteins , 2007, Neuroscience Research.

[48]  A. Sbarbati,et al.  Induction of neural-like differentiation in human mesenchymal stem cells derived from bone marrow, fat, spleen and thymus. , 2007, Bone.

[49]  C. Kuntz,et al.  Global expression of NGF promotes sympathetic axonal growth in CNS white matter but does not alter its parallel orientation , 2007, Experimental Neurology.

[50]  C. Hulsebosch,et al.  Human fetal neural stem cells grafted into contusion‐injured rat spinal cords improve behavior , 2007, Journal of neuroscience research.

[51]  M. Hájek,et al.  Transplantation of bone marrow stem cells as well as mobilization by granulocyte-colony stimulating factor promotes recovery after spinal cord injury in rats. , 2006, Journal of neurotrauma.

[52]  A. Caplan,et al.  Mesenchymal stem cells as trophic mediators , 2006, Journal of cellular biochemistry.

[53]  J. Schoenen,et al.  Delayed GM‐CSF treatment stimulates axonal regeneration and functional recovery in paraplegic rats via an increased BDNF expression by endogenous macrophages , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[54]  A. Asawachaicharn,et al.  Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis , 2006, Experimental Neurology.

[55]  D. Prockop,et al.  Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[56]  L. Rodríguez,et al.  Development of a rat model of spinal cord injury and cellular transplantation. , 2005, Transplantation proceedings.

[57]  G. Moonen,et al.  Plasticity of Cultured Mesenchymal Stem Cells: Switch from Nestin‐Positive to Excitable Neuron‐Like Phenotype , 2005, Stem cells.

[58]  J. Shumsky,et al.  Treatments for , 2004 .

[59]  Sherri S Schultz,et al.  Adult stem cell application in spinal cord injury. , 2005, Current drug targets.

[60]  P. Reier Cellular transplantation strategies for spinal cord injury and translational neurobiology , 2004, NeuroRX.

[61]  M. Chopp,et al.  Intravenous administration of marrow stromal cells (MSCs) increases the expression of growth factors in rat brain after traumatic brain injury. , 2004, Journal of neurotrauma.

[62]  C. Ide,et al.  Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation , 2004, Experimental Neurology.

[63]  M. Zurita,et al.  Functional recovery in chronic paraplegia after bone marrow stromal cells transplantation , 2004, Neuroreport.

[64]  K. Houkin,et al.  A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats , 2004, Brain Research.

[65]  F. Barry,et al.  Mesenchymal stem cells: clinical applications and biological characterization. , 2004, The international journal of biochemistry & cell biology.

[66]  M. Burnett,et al.  Marrow-Derived Stromal Cells Express Genes Encoding a Broad Spectrum of Arteriogenic Cytokines and Promote In Vitro and In Vivo Arteriogenesis Through Paracrine Mechanisms , 2004, Circulation research.

[67]  M. Tuszynski,et al.  Delayed grafting of BDNF and NT-3 producing fibroblasts into the injured spinal cord stimulates sprouting, partially rescues axotomized red nucleus neurons from loss and atrophy, and provides limited regeneration , 2003, Experimental Neurology.

[68]  K. Jin,et al.  Induction of neuronal markers in bone marrow cells: differential effects of growth factors and patterns of intracellular expression , 2003, Experimental Neurology.

[69]  G. Moonen,et al.  Regulation of neural markers nestin and GFAP expression by cultivated bone marrow stromal cells , 2003, Journal of Cell Science.

[70]  D. Soligo,et al.  Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. , 2002, Experimental hematology.

[71]  D. Čížková,et al.  A simple and reproducible model of spinal cord injury induced by epidural balloon inflation in the rat. , 2001, Journal of neurotrauma.

[72]  S. Ousman,et al.  MIP-1α, MCP-1, GM-CSF, and TNF-α Control the Immune Cell Response That Mediates Rapid Phagocytosis of Myelin from the Adult Mouse Spinal Cord , 2001, The Journal of Neuroscience.

[73]  M. Chopp,et al.  Adult bone marrow stromal cells administered intravenously to rats after traumatic brain injury migrate into brain and improve neurological outcome , 2001, Neuroreport.

[74]  M Chopp,et al.  Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation , 2000, Neuroreport.

[75]  L. Noble,et al.  Vascular events after spinal cord injury: contribution to secondary pathogenesis. , 2000, Physical therapy.

[76]  J. Kordower,et al.  Cellular Delivery of Trophic Factors for the Treatment of Huntington's Disease: Is Neuroprotection Possible? , 1999, Experimental Neurology.

[77]  G. Moonen,et al.  Grafts of meningeal fibroblasts in adult rat spinal cord lesion promote axonal regrowth. , 1999, Neuroreport.

[78]  L. Devi,et al.  Neurotrophic Factors Regulate Cathepsin S in Macrophages and Microglia: A Role in the Degradation of Myelin Basic Protein and Amyloid β Peptide , 1999, Molecular medicine.

[79]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[80]  G. Moonen,et al.  Effects of macrophage transplantation in the injured adult rat spinal cord: A combined immunocytochemical and biochemical study , 1998, Journal of neuroscience research.

[81]  K. Kawamoto,et al.  Functional properties of murine macrophages promoted by nerve growth factor. , 1996, Blood.

[82]  G. Moonen,et al.  Effects of Schwann cell transplantation in a contusion model of rat spinal cord injury , 1996, Journal of neuroscience research.

[83]  S. Waxman,et al.  Restoration of Normal Conduction Properties in Demyelinated Spinal Cord Axons in the Adult Rat by Transplantation of Exogenous Schwann Cells , 1996, The Journal of Neuroscience.

[84]  D. Basso,et al.  A sensitive and reliable locomotor rating scale for open field testing in rats. , 1995, Journal of neurotrauma.

[85]  C H Tator,et al.  Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. , 1991, Journal of neurosurgery.

[86]  Jee-Yin Ahn,et al.  Neuroprotection signaling pathway of nerve growth factor and brain-derived neurotrophic factor against staurosporine induced apoptosis in hippocampal H19-7/IGF-IR , 2010, Experimental & Molecular Medicine.

[87]  J. Neuwirth,et al.  Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury. , 2006, Cell transplantation.

[88]  K. Houkin,et al.  Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[89]  S. Ousman,et al.  MIP-1alpha, MCP-1, GM-CSF, and TNF-alpha control the immune cell response that mediates rapid phagocytosis of myelin from the adult mouse spinal cord. , 2001, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[90]  M. Sofroniew,et al.  Nerve growth factor signaling, neuroprotection, and neural repair. , 2001, Annual review of neuroscience.

[91]  Alexander Sasha Rabchevsky,et al.  Role of microglia in postinjury repair and regeneration of the CNS , 1998 .

[92]  Evon M. O. Abu-Taieh,et al.  Comparative study , 2003, BMJ : British Medical Journal.